Issue brief |
01 September 2020

Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down


This brief examines the background and unexpected consequences of the Xpert MTB/RIF buy-down; applies lessons learned to the ongoing development of COVID-19 diagnostic tests and efforts to scale up access to these tests; and provides recommendations and pro-access conditions that should be applied to R&D funding, buy-down, and other market intervention agreements for COVID-19 diagnostics.

Continue Reading